Scancell Holdings (SCLP.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold SCLP.L in your mock portfolio yet.
The negative EPS and PE ratio indicate that Scancell Holdings is currently loss-making, with no visible profitability on a per-share basis. This positions the stock more as a speculative, early‑stage or R&D‑heavy play rather than a cash‑generating business. Without clear evidence of an imminent path to profitability, the financial profile is a headwind for the stock.
The stock has fallen 31.3% over the last month and is trading well below its 200‑day moving average, indicating a strong downtrend. An RSI of 20.02 shows the shares are deeply oversold, which can sometimes precede a short‑term bounce but also reflects heavy recent selling pressure. Overall, the technical picture is weak, with momentum clearly negative.
Alternative data for Scancell Holdings is modest and relatively stagnant, neither strongly confirming nor contradicting the bearish technical and financial picture. Website traffic is very low, job postings are flat at zero, and social media follower growth is minimal. These signals suggest limited current commercial traction or scaling activity, but they are not decisive on their own for a small, likely R&D‑focused company.
Combining negative earnings, a sharp recent price decline, and a technically weak chart with muted alternative data signals yields an overall bearish view on Scancell Holdings at this time. While the oversold RSI could enable short‑term technical rebounds, the lack of profitability and subdued engagement metrics weigh on the medium‑term outlook. Investors are currently relying more on future potential than on demonstrated financial performance.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started